They also promote the migration of ovarian cancer cells to the omentum through chemokine release that interact with chemokine receptor 1 (CCR1) on ovarian cancer cells and associate with activation of ERK1/2 and PI3K pathways (181) (Figure 4B). This evidence concerns the gene CCR1 and ovarian carcinoma.